P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans

Crossover study
DOI: 10.5414/cpp38161 Publication Date: 2011-03-25T08:41:07Z
ABSTRACT
Increased bioavailability of the P-glycoprotein (Pgp) substrates digoxin and cyclosporin due to erythromycin has been observed in vivo. The aim present study was investigate effect orally administered on oral beta-blocker talinolol. Talinolol is a suitable model compound for Pgp drug-drug interaction studies its Pgp-related active intestinal secretion lack any significant metabolism.In randomized crossover study, pharmacokinetics talinolol (50 mg) after concomitant single dose (2 g) or placebo were investigated 9 healthy men. Concentrations measured serum urine by HPLC.The area under curve concentrations from 0 24 h (AUC(0-24)) maximum (Cmax) significantly increased administration compared placebo. t(max) values reduced. renal clearance (CLR) unchanged co-administration there small but statistically decrease elimination half-life (t1/2). Serum correlate with results derived concentration measurement. One subject suffered moderate diarrhea excluded analysis.We suggest that increase caused net absorption inhibition erythromycin.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (123)